4//SEC Filing
Essetifin SPA 4
Accession 0001213900-20-010932
CIK 0001211583other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:25 PM ET
Size
17.7 KB
Accession
0001213900-20-010932
Insider Transaction Report
Form 4
Cavazza Enrico
10% Owner
Transactions
- Purchase
Common Stock
2020-04-30$6.25/sh+768,000$4,800,000→ 3,993,694 total
Cavazza Preta Martina
10% Owner
Transactions
- Purchase
Common Stock
2020-04-30$6.25/sh+768,000$4,800,000→ 3,993,694 total
Cavazza Francesca
10% Owner
Transactions
- Purchase
Common Stock
2020-04-30$6.25/sh+768,000$4,800,000→ 3,993,694 total
Cavazza Silvia
10% Owner
Transactions
- Purchase
Common Stock
2020-04-30$6.25/sh+768,000$4,800,000→ 3,993,694 total
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
- Purchase
Common Stock
2020-04-30$6.25/sh+768,000$4,800,000→ 3,993,694 total
CAVAZZA PAOLO
10% Owner
Transactions
- Purchase
Common Stock
2020-04-30$6.25/sh+768,000$4,800,000→ 3,993,694 total
Footnotes (2)
- [F1]Such shares were purchased in connection with an underwritten public offering by the issuer, which closed on May 4, 2020.
- [F2]Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001092601
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 5:25 PM ET
- Size
- 17.7 KB